FH Ortho received FDA clearance for new base plates

The US Food and Drug Administration approved FH Ortho’s ARROW Reverse Shoulder “long keel” and “short keel” glenoid base plate for patients with severe shoulder arthropathy, a ‘grossly’ deficient rotator cuff or a previously failed shoulder joint replacement with a ‘grossly’ deficient rotator cuff.

The humeral stem is meant for cemented or cementless application and the metal-back glenoid baseplate is intended for cementless application with the addition of bone screws for fixation. It is also necessary for the patient to have a functional deltoid muscle and adequate glenoid bone stock.

More articles on devices:
Bacterin’s Q1 total net revenue up again — 5 key takeaways
NuVasive shares’ mean target price set at $54
Bacterin, Zimmer, SpineGuard & more — 19 key notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Next Up in Spinal Tech

FH Ortho received FDA clearance for new base plates

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Next Up in Spinal Tech

5 key spine technologies in 2026 — and the gate each still has to clear

Highmark to cover Mainstay Medical neurostimulation therapy

Spinal Elements launches new titanium TLIF implant

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Next Up in Spinal Tech

5 key spine technologies in 2026 — and the gate each still has to clear

Highmark to cover Mainstay Medical neurostimulation therapy

Spinal Elements launches new titanium TLIF implant

Join the spine leaders & surgeons who start their day with Becker's